A large study from Germany suggests that a readily available medication, Actos (Pioglitazone) may prevent Alzheimer’s disease from developing in diabetic patients, reducing their risk by 50%.
This study, looked at the records over 150,000 patients and the connection between taking Actos long term, and reduced Alzheimer’s risk, was substantial…about 50%.
This medication had been controversial int he past, in treating diabetes because of it’s questionable association with bladder cancer. Â Subsequent studies have demonstrated NO CONNECTION WITH BLADDER CANCER, and with this new data, there is reason to show renewed interest in this medication.
Read more >>>HERE<<<<